Ramírez-Paesano C

Language: Spanish
References: 10
Page: 7-9
PDF size: 90.58 Kb.

Text Extraction

No abstract

REFERENCES

1. Greco M, Landoni G, et al. Remifentanyl in Cardiac Surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anaesth. 2012;26:110-116.

2. Wong Gordon TC, Huang Z, et al. Remifentanyl reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anaesth. 2010;24:790-796.

3. Krzych LJ, Szurlej D, Bochenek A. Rationale for propofol use in cardiac surgery. J Cardiothorac Vasc Anaesth. 2009;23:878-885.

4. Jakobsen CJ, Berg H, et al. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anaesth. 2007;21:664-671.

5. De Hert SG, ten Broecke PW, et al. Sevoflurane but no propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002;97:42-49.

6. Tritapepe L, Landoni G, et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol. 2007;24:231-232.

7. Zangrillo A, Testa V, et al. Volatile agents for cardiac protection in noncardiac surgery: a randomized controlled study. J Cardiothorac Vasc Anaesth. 2011;25:902-907.

8. Kim TY, Kim DK, Yoon TG, et al. Myocardial injury in remifentanyl-based anaesthesia for off-pump coronary artery bypass surgery: an equipotent dose of sevoflurane versus propofol. Anaesth Intensive Care. 2011;39:418-425.

9. Covello RD, Ruggeri L, Landoni G, et al. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anesthesiol. 2010;76:100-108.

10. Ruggeri L, Landoni G, Guarracino F, et al. Remifentanyl in critical ill cardiac patients. Ann Card Anaesth. 2011;14:6-12.